Potentiating bacterial cancer therapy using hydroxychloroquine liposomes

VNP20009 preferably invades tumor cells. HCQ liposomes target tumors passively via the EPR effect and deliver HCQ to arrest autophagy induced by VNP20009, thus enhance bacteria-mediated cancer cell killing.151